RetinAI

RetinAI's Discovery platform stores and organizes eye imaging data and runs AI analysis on it for clinics, hospitals, pharma companies and researchers. It aims to speed up clinical workflows and studies in diseases such as AMD and diabetic retinopathy.

Discovery handles OCT scans, fundus images, DICOM datasets, PDFs and standard image files in one place, then harmonizes and analyzes the data to track disease progression and treatment outcomes. Its OCT Atlas algorithm is CE-marked for clinical use across AMD, diabetic retinopathy, DME and glaucoma.

Pharma teams use it for clinical studies and real-world evidence, with secure cloud access for collaboration across sites. RetinAI is part of the Swiss company Ikerian, and it partners with device makers such as Heidelberg Engineering.